Does early cardiovascular therapy intensification improve long-term adverse cardiac outcomes in patients with elevated troponin I levels after major vascular surgery?
Early intensification of cardiovascular therapy according to ACS guidelines may improve long-term outcomes in patients with postoperative troponin elevation after noncardiac surgery.
The main finding of this study was that in patients with elevated troponin I levels after noncardiac surgery, long-term adverse cardiac outcomes may likely be improved by following evidence-based recommendations for the medical management of acute coronary syndromes.
Foucrier et al. (Tue,) studied this question.